HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 357 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,025,184 | -6.3% | 69,368 | -16.7% | 0.03% | 0.0% |
| Q2 2023 | $8,566,994 | -47.4% | 83,296 | -44.2% | 0.03% | -52.8% |
| Q1 2023 | $16,296,676 | -1.8% | 149,319 | +2.4% | 0.07% | -11.1% |
| Q4 2022 | $16,593,406 | +72.8% | 145,812 | -6.0% | 0.08% | +62.0% |
| Q3 2022 | $9,600,000 | +4449.8% | 155,116 | +7941.3% | 0.05% | +4900.0% |
| Q3 2021 | $211,000 | -58.1% | 1,929 | -64.7% | 0.00% | -50.0% |
| Q1 2021 | $503,000 | -91.6% | 5,466 | -93.3% | 0.00% | -92.3% |
| Q4 2020 | $6,003,000 | +12.4% | 82,070 | +19.4% | 0.03% | +4.0% |
| Q3 2020 | $5,341,000 | +87.7% | 68,751 | +34.3% | 0.02% | +78.6% |
| Q2 2020 | $2,845,000 | +412.6% | 51,182 | +173.3% | 0.01% | +250.0% |
| Q1 2020 | $555,000 | +13.3% | 18,728 | +38.5% | 0.00% | +100.0% |
| Q4 2019 | $490,000 | -47.0% | 13,523 | -60.2% | 0.00% | -60.0% |
| Q3 2019 | $925,000 | -39.9% | 33,958 | -47.0% | 0.01% | -37.5% |
| Q2 2019 | $1,540,000 | – | 64,025 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paulson & Co. | 6,100,000 | $377,529,000 | 27.63% |
| Kopp Family Office, LLC | 542,543 | $33,578,000 | 27.33% |
| Prosight Management, LP | 303,000 | $18,753,000 | 10.05% |
| Eversept Partners, LP | 1,269,591 | $78,574,987 | 6.81% |
| Octagon Capital Advisors LP | 624,500 | $38,650,000 | 6.67% |
| Avoro Capital Advisors LLC | 5,125,000 | $317,186,000 | 5.86% |
| 1492 Capital Management LLC | 119,836 | $7,417,000 | 5.34% |
| Velan Capital Investment Management LP | 68,829 | $4,260,000 | 4.22% |
| Deep Track Capital, LP | 1,462,800 | $90,533,000 | 4.15% |
| Ally Bridge Group (NY) LLC | 74,262 | $4,596,000 | 3.03% |